Gossamer Bio (GOSS) Retained Earnings (2018 - 2026)
Gossamer Bio (GOSS) posted quarterly Retained Earnings of -$1.5 billion for Q1 2026, down 13.82% year-over-year from -$1.7 billion in Q1 2025, and down 28752.2% quarter-over-quarter from -$5.1 million in Q4 2025.
Gossamer Bio (GOSS) Retained Earnings (2018 - 2026) Analysis & Trends
Gossamer Bio's Retained Earnings history runs 9 years deep, the most recent figure standing at -$1.5 billion for Q1 2026.
- In Q1 2026, Retained Earnings fell 13.82% year-over-year to -$1.5 billion; the TTM figure through Mar 2026 stood at -$1.5 billion (down 13.82% YoY), while the FY2025 annual figure was -$5.1 million, down 533.05% from the prior year.
- Retained Earnings for Q1 2026 stood at -$1.5 billion, down from -$5.1 million in the prior quarter.
- The five-year high for Retained Earnings was $1.2 million in Q4 2024, with the low at -$1.5 billion in Q1 2026.
- The 5-year median for Retained Earnings is -$1.1 billion (2023), against an average of -$797.7 million.
- The sharpest annual moves came in 2022 and 2024: Retained Earnings tumbled 334806.57% in 2022, then jumped 100.1% in 2024.
- Gossamer Bio's Retained Earnings stood at -$574000.0 in 2022, then tumbled by 211056.79% to -$1.2 billion in 2023, then surged by 100.1% to $1.2 million in 2024, then tumbled by 533.05% to -$5.1 million in 2025, then plunged by 28752.2% to -$1.5 billion in 2026.
- Business Quant data shows GOSS's Retained Earnings at -$1.5 billion in Q1 2026, -$5.1 million in Q4 2025, and -$1.4 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.89 Bn | 131.04 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 86.05 Bn | 78.06 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.38 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 55.46 Bn | 50.32 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 27.70 Bn | 9.30 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | 4.38 Bn |
| 10 | Gossamer Bio | 51.17 Mn | -5.86 Mn | - | -1.47 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.47 Bn |
| Mar 31, 2026 | -1.49 Bn |
| Dec 31, 2025 | -5.15 Mn |
| Sep 30, 2025 | -1.39 Bn |
| Jun 30, 2025 | -1.34 Bn |
| Mar 31, 2025 | -1.31 Bn |
| Dec 31, 2024 | 1.19 Mn |
| Sep 30, 2024 | -1.24 Bn |
| Jun 30, 2024 | -1.20 Bn |
| Mar 31, 2024 | -1.25 Bn |
| Dec 31, 2023 | -1.21 Bn |
| Sep 30, 2023 | -618,000.00 |
| Jun 30, 2023 | -1.12 Bn |
| Mar 31, 2023 | -1.08 Bn |
| Dec 31, 2022 | -574,000.00 |
| Sep 30, 2022 | -585,000.00 |
| Jun 30, 2022 | -917.10 Mn |
| Mar 31, 2022 | -340,000.00 |
| Dec 31, 2021 | -811.53 Mn |
| Sep 30, 2021 | -755.25 Mn |